User profiles for Christopher P Cheyne

Christopher P Cheyne

Senior Research Fellow, University of Liverpool
Verified email at liverpool.ac.uk
Cited by 2363

IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study

GA Baker, RL Bromley, M Briggs, CP Cheyne… - Neurology, 2015 - AAN Enterprises
Objective: To delineate the risk to child IQ associated with frequently prescribed antiepileptic
drugs. Methods: Children born to women with epilepsy (n = 243) and women without …

Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study

M García-Fiñana, DM Hughes, CP Cheyne, G Burnside… - bmj, 2021 - bmj.com
Objective To assess the performance of the SARS-CoV-2 antigen rapid lateral flow test (LFT)
versus polymerase chain reaction testing in the asymptomatic general population attending …

[HTML][HTML] High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery

…, LR Hepworth, C Howard, KL Hanna, CP Cheyne… - PloS one, 2019 - journals.plos.org
Background Visual problems are an under-reported sequela following stroke. The aim of
this study is to report annual incidence and point prevalence of visual problems in an acute …

Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate

…, R Calderbank, CP Cheyne, C Rooney, P Trayner… - Neurology, 2016 - AAN Enterprises
Objective: To investigate the effects of prenatal exposure to monotherapy levetiracetam,
topiramate, and valproate on child cognitive functioning. Methods: This was a cross-sectional …

[HTML][HTML] Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of …

…, B Barr, G Burnside, CP Cheyne… - The Lancet Regional …, 2021 - thelancet.com
Background Large-scale asymptomatic testing of communities in Liverpool (UK) for SARS-CoV-2
was used as a public health tool for containing COVID-19. The aim of the study is to …

[HTML][HTML] Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation …

…, RH Mulholland, NI Lone, CP Cheyne… - The Lancet …, 2021 - thelancet.com
Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …

[HTML][HTML] Metformin, a potential role in age-related macular degeneration: a systematic review and meta-analysis

DF Romdhoniyyah, SP Harding, CP Cheyne… - Ophthalmology and …, 2021 - Springer
Background Currently, no generally approved medical treatment can delay the onset of age-related
macular degeneration (AMD) or slow the progression of degenerative changes. …

[HTML][HTML] Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine

…, DM Broadbent, M García-Fiñana, CP Cheyne… - Diabetologia, 2017 - Springer
Aims/hypothesis Individualised variable-interval risk-based screening offers better targeting
and improved cost-effectiveness in screening for diabetic retinopathy. We developed a …

[HTML][HTML] Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT

DM Broadbent, A Wang, CP Cheyne, M James, J Lathe… - Diabetologia, 2021 - Springer
Aims/hypothesis Using variable diabetic retinopathy screening intervals, informed by
personal risk levels, offers improved engagement of people with diabetes and reallocation of …

Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules

…, DM Hughes, CP Cheyne… - Diabetes, Obesity …, 2019 - Wiley Online Library
Aims To evaluate our proposed multivariate approach to identify patients who will develop
sight‐threatening diabetic retinopathy (STDR) within a 1‐year screen interval, and explore the …